US measles cases on track for a record in 2019

2 April 2019

The number of measles cases recorded in the USA was higher in the first quarter of 2019 than in the whole of 2018, according to figures from the Centers for Disease Control and Prevention (CDC).

With 387 reported so far, the number of cases is on course to exceed the 667 of 2014, which is currently the highest annual total since measles was, in theory, eliminated from the USA in 2000.

Since then, growing pockets of unvaccinated people and an increase in the number of travelers who pick up measles abroad and bring it back to the USA, have led to a new rise in the frequency of outbreaks and cases.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK